NEWS
Jun 04, 2025

A Statement Regarding Peptide Sourcing

ADVISORY BULLETIN

The SSRP is a medical education institute. We do not sell peptides. Our platform serves as a global scientific forum which promotes peptide science alongside cellular medicine education and clinical applications. It enables open dialogue and innovation through its support of the highest ethical and legal standards.

Our mission is to “improve patient outcomes, together”. This includes informing you how to protect both your patients and your license. Please take the time to discern the differences in peptide sourcing. This information is crucial for the safety of your patients, and the legal risks to you and your practice.

RUO Peptides

Some companies solicit research-use-only (RUO) peptides that exist outside human drug approval and/or prescription requirements. These products are for laboratory, educational, and investigational purposes only, not clinical, therapeutic, or diagnostic applications. They are labeled “not for human use” or “for research use only” as a legal disclaimer in an attempt to remove liability from the manufacturer in the context of human administration. Clinically prescribing or administering RUO peptides — even if they are third-party tested — violates federal and state board of pharmacy laws. The FDA sees this as misbranding and distribution of unapproved new drugs, and it’s legally indefensible in a court of law. Providers can get sued, have their license suspended, and face jail time for offering RUO meds directly from their clinics.

What If They Claim They’re Not RUO?

Even when a vendor claims their peptides are “pharma-grade” or “direct from manufacturer,” unless they are a licensed pharmacy, they are not legally authorized to sell medications for human use — and neither 3rd-party testing nor disclaimers remove this liability.

Compounded Peptides

If you have specific questions about how to source peptides appropriately, please reach out to your preferred compounding pharmacy. If you do not have one, we have several listed publicly on our website. Compounding pharmacies exist inside of a highly regulated, prescription drug supply chain. If you cannot find a particular peptide within their formulary, ask about substitutes they offer. If they do not ship to your state, ask your local compounding pharmacist how you can support them in their efforts to continue providing legitimate custom peptides for patients.

In Summary

Online injectable peptides that are not received from a legitimate compounding pharmacy are illegal. Period. Clinics can get raided, and providers can get shut down, if they are found to be prescribing them and storing them with intent to use clinically.

Compounding pharmacies compound drugs for human use for individually identified patients pursuant to a medical provider’s prescription. They ship directly to the patient, and patients’ rights to peptide therapy are protected under federal patient personal use laws.

Please consult with your legal counsel to ensure that, if you’re going to provide appropriate clinical guidance on peptide therapy, you’re doing so in a way that protects your patient’s health and your ability to continue to better ensure their safety.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Jun 22, 2026
Ep. 093 - The Phosphatidylcholine Pathway
Preview Only
Rabbit Holes – Episode 093

The Phosphatidylcholine Pathway

Dr. Seeds expands on Journal Club Episode 92 to explore the role of phosphatidylcholine in lipid metabolism, methylation, and mitochondrial integrity during aging. He also highlights how estrogen loss may impact this pathway, especially in pre- and post-menopausal women.

Preview Only — Become a member for full access
Foundational Foundational
The Cell Code
A Cellular Medicine Perspective on Health, Aging, and Disease Cell Code is a structured walk through ten core molecular pathways that shape Cellular Medicine. For each pathway, the course presents twenty questions, beginning with foundational mechanisms and moving into applied...
31 Lessons
Self-paced
View Course
VIDEO
Cellular Medicine Mondays
Jun 15, 2026
Ep. 092 - Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Preview Only
Journal Club – Episode 092

Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging

Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.

Preview Only — Become a member for full access
SSRP Institute Jun 10, 2026
PCOS Name Change to PMOS: Polyendocrine Metabolic Ovarian Syndrome
HEADLINE SCIENCE An international body of medical scientists in obstetrics and gynecology, endocrinology, and other speciality societies, and other physicians announced the result of a multi-year process to formally change the name of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change, published in May 2026 in The Lancet, aims to address […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Jun 8, 2026
Ep. 091 - Dr. Seeds’ Office Hours
Preview Only
ARTICLE
William Seeds, MD
Jun 3, 2026
GLP-1 and the Gut–Musculoskeletal Axis: A Clinical Summary
William Seeds, MD Jun 3, 2026
GLP-1 and the Gut–Musculoskeletal Axis: A Clinical Summary
The Overlooked Connection: Dysbiosis and Degenerative Disease Degenerative musculoskeletal diseases, including osteoarthritis (OA), osteoporosis (OP), sarcopenia (SP), and intervertebral disc degeneration (IVDD), affect well over a billion people globally and share three core pathological features: chronic inflammation, oxidative stress, and dysregulated cell death. What is increasingly clear, and clinically underappreciated, is that gut microbiota (GM) […]
READ ARTICLE
Certification
Peptide Therapy Certification 2026
Clinical peptides are proving to be an increasingly impactful tool in a physician’s patient care toolkit. With wide-ranging applicability across cardiology, pediatrics, fertility, orthopaedics, and more, peptide therapy can help you deliver more individualized care and create better outcomes for...
REGISTER NOW
Foundational Foundational
Peptide Therapy Foundations: Skin Resilience
This course examines the peptides applied to the skin and its appearance: the topical signal peptides that influence collagen and expression lines, the copper-binding repair peptide, and the melanocortin agonists that act on pigmentation. It is written for clinicians who...
6 Lessons
3 Hours 5 Minutes
View Course
Foundational Foundational
Peptide Therapy Foundations: Hormonal & Sexual Health
This course examines the peptides that act on sexual function and the hormonal axis that governs reproduction. It is written for clinicians who want to understand how these agents influence desire, arousal, and the upstream signaling of the reproductive system,...
3 Lessons
2 Hours 10 Minutes
View Course
VIDEO
Cellular Medicine Mondays
Jun 1, 2026
Ep. 090 - Dr. Seeds’ Office Hours - Bonus Episode
Preview Only
Dr. Seeds’ Office Hours – Episode 090

In this bonus episode from the MM15 Virtual Summit, Dr. Seeds addresses an important question around the use of GLP-1s for metabolic balancing in patients who do not need to lose weight. He shares his perspective on what may be considered microdosing, along with the clinical thought process he uses when determining appropriate dosing in these more nuanced cases.

Additional questions from the MM15 Virtual Summit can be found in our accompanying article here: [insert article link]

Access the full MM15 Course here: Mastermind 15 on Aesthetics

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.